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ABSTRACT
The choline analog homocholine is not acetylated

~vitro

by

choline-0-acetyltransferase (ChAT, EC 2.3. 1.6) which is solubilized
by 100 mM sodium phosphate buffer washes of a crude vesicular fraction of mouse forebrain.

However, both homocholine and choline are

acetylated by a form of ChAT which is non-ionically associated with
a subcellular fraction of mouse forebrain containing membrane associated organelles and occluded ACh (P 4 ). Acetylation of homocholine
by membrane associated ChAT is saturable. 4-(l-Naphthylvinyl)
pyridine (NVP) inhibits the acetylation of both choline (60%) and
homocholine (40%) by membrane associated ChAT but reduces the acetylation of only choline by soluble ChAT (76%).

Choline and homocho-

line serve as competitive alternative substrates for the same membrane associated ChAT whereas homocholine only acts as a competitive
inhibitor of choline acetylation by soluble ChAT.

Acetylhomocholine

competitively inhibits the acetylation of choline by both soluble
and membrane associated ChAT more dramatically than does the natural
end product ACh.
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INTRODUCTION
According to the classical model of a cholinergic nerve ending,
acetylcholine (ACh) is synthesized by choline-0-acetyltransferase located in the cytoplasm of the nerve ending.

ACh is then transferred

into the synaptic vesicles where it is stored.

Depolarization of

the nerve ending stimulates the release of ACh from vesicles by a Ca++
dependent exocytotic process.
Presently not all studies support the classical model.

In par-

ticular, the transfer of ACh from the cytoplasm to vesicles has not
been demonstrated (Marchbanks and Israel, 1972; Suszkiw, 1976; Nelson
et~.,

1980).

Also not all nerve ending ChAT is soluble.

Some ap-

pears to be non-ionically associated with a crude vesicular fraction.
Rec~nt

studies using the choline analog homocholine suggest that

ACh released upon depolarization may not necessarily be synthesized
by soluble ChAT.

Homocholine is similar to choline in most all as-

pects of cholinergic metabolism.

However, homocholine differs from

choline in one very important respect - it is not acetylated by soluble ChAT (see lit. review), although it is acetylated by slices of
rat cerebral cortex (Boksa and Collier, 1980).

Therefore the objec-

tive of this study was to determine if an alternative form of ChAT,
which is non-ionically associated with a crude vesicular fraction,
can acetylate homocholine.
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LITERATURE REVIEW
Historical
Acetylcholine (ACh) is a neurotransmitter at autonomic ganglia, the
neuromuscular junction, at parasympathetic and some sympathetic neuroeffector junctions, and a putative neurotransmitter in the central nervous system.

Katz and his associates (Fatt and Katz, 1951, 1952, 1953;

del Castillo and Katz, 1954) presented evidence that neurotransmitter
released spontaneously from nerve endings of the neuromuscular junction
(ACh) in multi-molecular quanta generates post-synaptic miniature endplate potentials (m.e.p.p.s.).
qucy of m.e.p.p.s.

Nerve stimulation increases the fre-

Later, several investigators (e.g. Palade and

Palay, 1954; deRobertis and Bennett, 1954, 1955) reported that electron microscopy revealed the presence of large numbers of spherical
organelles ("synaptic vesicles

11

)

contained within nerve endings. These

synaptic vesicles were considered to be the morphological correlates
of the multi-molecular quanta reported earlier.

The demonstration of

quantal release of neurotransmitter, and the observation of synaptic
vesicles in nerve endings led to the formulation of the vesicle hypothesis (first described by del Castillo and Katz, 1957).

According

to this hypothesis, ACh which is stored in synaptic vesicles is released into the synaptic cleft upon nerve stimulation, or depolarization, by a Ca++ dependent exocytotic process. Birks and Macintosh
I
(1961) demonstrated that the sympathetic gangkion contains several ~
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pools of ACh.

One pool, known as "stationary" ACh (approximately 15%

of the total ACh content of the ganglion) was thought to be contained
within nerve axons and cell bodies, and remains unaltered upon nerve
stimulation.

The other pool (remaining 85% of total ACh), termed

"depot" ACh, was thought to be present in nerve endings, and was at
least partially releasable upon depolarization.

These authors noted

that this latter pool seemed to be made up of two subfractions, one
of which is smaller than the other and more readily releasable upon
depolarization.

In 1962, Gray and Whittaker isolated nerve ending

particles with synaptic vesicles contained within them (synaptosomes)
from homogenates of guinea-pig brain.

Hebb and Whittaker (1958) also

presented evidence suggesting that the synaptosomes contained "bound"
ACh, which corresponds to the depot ACh of Birks and Macintosh (1961).
In 1964, Whittaker

et~·

reported that hypo-osmotic rupture of synap-

tosomes released approximately 50% of the bound ACh (S 3 fraction, cytoplasmic or labile-bound) while the other 50% remained associated
with membrane fragments (P 3 fraction, vesicular or stable-bound). The
stable-bound ACh was bimodally distributed in subcellular fractions
of hypo-osmotically ruptured synaptosomes spun through a discontinuous sucrose gradient:

one fraction (0) was enriched in synaptic

vesicles and the other (H) contained large membrane fragments, then
thought to be only nondisrupted synaptosomes.
using j.!:!_ vivo (Chakrin

~t ~.,

banks, 197la,b; Molenaar

1972)

et~.,

or~

Several investigators

vitro (Richter and March-

1973) techniques, reported that after

labelling the subcellular pools of ACh to different specific activities using the precursor labelled choline, the specific activity of
the ACh subsequently released was considerably higher than that con-
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tained in either the cytoplasmic or vesicle-bound stores.

These re-

sults indicate that newly synthesized ACh is preferentially released in
response to nerve stimulation, and also suggest that a small subpool
of vesicles may turn over its ACh content faster than the main vesicle
population.

Barker~!

..!l_. (1972) then demonstrated that a tail vein

injection of labelled choline into the guinea pig led to labelling of
ACh in the different subcellular fractions of ruptured synaptosomes of
the cortex to different specific activities, also suggesting that different pools of ACh turn over at different rates.

Fraction H (contain-

ing the large neuronal membrane fragments and some membrane associated
vesicles) had the highest specific activity, and fraction D (containing monooisperse synaptic vesicles) had the lowest specific activity
of ACh.

Soluble (cytoplasmic, or labile-bound) ACh had an intermedi-

ate specific activity.
In the early 1970s, most investigators agreed that most if not all
of the enzyme which synthesizes ACh, choline-0-acetyltransferase (ChAT)
is soluble within the nerve ending (see review on the subcellular location of ChAT).

Therefore, based on the experimental evidence sum-

marized thus far, and the evidence that most all ChAT is cytoplasmic,
the classical model of the cholinergic nerve ending was developed.
According to this model, all nerve ending ACh is synthesized by soluble ChAT.

ACh is then transported into vesicles where it is stored,

until depolarization stimulates the release of ACh by exocytosis.
mentioned earlier, not all studies support this model.

As

Although at-

tempted by several investigators, using vesicle fractions (Marchbanks
and Israel, 1972; Nelson et a]_., 1980) or vesicle ghosts (Suszkiw,
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1977) transfer of ACh from cytop1asm into vesicles above diffusional
levels has never been demonstrated.
Another alternative hypothesis presented, from studies using
Torpedo electroplaque (see review by Israel, Dunant, and Manaranche,
1979), was that ACh is synthesized by cytoplasmic ChAT, and may be
released directly from the cytoplasm in response to depolarization.
Ca++ regulates gates in the neuronal membrane through which ACh is
thought to be released during depolarization.

In this case the ves-

icles serve only as storage sites for ACh.
The development of freeze-fracture techniques has provided evidence that ACh is released from nerve ending vesicles by exocytosis.
Heuser and Reese (1973) and Heuser

et~-

(1974) have observed clus-

ters of "dimples" in the presynaptic membrane in a regular array
around "active zones."

Thin sections of similar tissues reveal the

presence of numerous vesicles clustered near electron-dense regions
in the neuronal membrane postulated to be the active-zones of release.

These investigators also found that nerve stimulation increases

the number of dimples adjacent to the active zones.

The dimples are

thought to be vesicles in the process of merging with and collapsing
into the neuronal membrane during exocytosis.
Recently Katz and Mi1edi (1977) and Gorio et

~l·

(1978) have pre-

sented studies suggestng that ACh may be re1eased from nerve endings
by more than one process, as follows:

1) Ca++ dependent depolarized

release (generating electrophysiological end plate potentials); 2)
Ca++ dependent spontaneous re1ease (generating m.e.p.p.s.); and 3) Ca++
independent spontaneous release (generating background "noise," thought
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to account for approximately 90% of spontaneous release, Katz and
Miledi, 1977).

Carroll and Aspry (1980) have also presented evidence

that these different forms of ACh release may originate from different subcellular pools of ACh within nerve endings.

The functional

significance of these several forms of release remains to be elucidated.
Subcellular location of ChAT
The subcellular location of ChAT was the subject of controversy
for a number of years.

Hebb and her coworkers (Hebb and Smallman,

1956; Hebb and Whittaker, 1958) demonstrated that ChAT in brain homogenates is partially soluble
11

11

and partially "particle bound."

The

soluble ChAT is that which originates from the disrupted nerve axons
and cell bodies, and the particle bound ChAT (which represents the majority of ChAT in brain) is that which is present in synaptosomes.
Hypo-osmotic rupture of synaptosomes releases their contents and different groups of investigators isolated ChAT in different subcellular
fractions.

Whittaker and his coworkers (Whittaker, Michaelson and

Kirkland, 1964) recovered ChAT in a soluble cytoplasmic fraction of
ruptured synaptosomes, which is removed from the occluded ACh stores
(vesicle fractions).

deRobertis et al. (1963) found that ChAT was

associated with a subcellular fraction which did contain occluded ACh.
Initially the difference was attributed simply to species variations
(Tucek, 1966 a,b).

However, the work of Fonnum (1967, 1968) appeared

to resolve the situation.

He found that the subcellular location

from which ChAT was recovered depended on the pH and ionic strength
of the suspending medium.

Positively charged ChAT binds to the nega-

tively charged membranes more readily at a low pH and low ionic
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strength, and can be removed by washing the nerve ending fractions with
a high ionic strength buffer.

Also he found that rat and rabbit brain

enzymes (which deRobertis studied) were much more resistant to these
effects than guinea-pig (which Whittaker used) and pigeon enzymes.
Fonnum concluded (1968) that at physiological pH and ionic strength
"much if not all of the [ChAT] must be in a free form,

11

and this con-

cept has been generally accepted until recently.
Several investigators have also attempted to establish the subcellular location of ChAT using electron microscopic histochemical
techniques.

Kasa (1970, 1975), utilizing Pb capture of Coenzyme A,

found the reaction product in the cytoplasm, and adsorbed to mitochondria and vesicles, but not within vesicles.

However, Fiegenson

and Barrnett (1977) using different histochemical techniques (utilizing Mn++ and ferrocyanide) found reaction product within the vesicles,
and the appearance of the product was sensitive to inhibition by the
ChAT inhibitor 4(1-Naphthyvinyl)pyridine (NVP).

Therefore, based on

cytochemical techniques, the subcellular location of ChAT was still
somewhat controversial.
ChAT from mammalian tissue can be separated into several molecular forms on the basis of isoelectric point (e.g. White and Wu, 1973,c).
It is not presently clear which form (or forms) is (are) functionally
significant in neurotransmission.

Krell and Goldberg (1975) reported

that the ChAT inhibitor NVP, when injected into mouse or guinea-pig,
inhibited soluble ChAT but there was no significant alteration in
steady state brain ACh levels.

~ven

at a neutral pH and high ionic

strength, a certain amount (20-40%) of nerve ending ChAT remains insoluble.

Hebb (1972) has suggested that "Even if reduced to 10%, the

enzyme remaining bound, if strategically located, could be responsible
for the production of as much ACh as is present in the storage system,
the 'depot' ACh of Birks and Macintosh

11

(1961).

Recently Smith and Carroll (1980) havademonstrated that a crude
vesicular fraction (P 3 ) of mouse forebrain, prepared from hypo-osmo. tically ruptured synaptosomes, retains approximately 15% of synaptosomal ChAT activity, after washing the fraction twice with 100 mM sodium phosphate buffer at a pH of 7.4.

ChAT which is solubilized by the

high ionic strength buffer washes appears to differ from the bound
ChAT, in that it is more sensitive to inhibition by ACh and NVP, and
is also more dependent on Na+.

The fraction (P 3) which contains membrane bound ChAT also contains stable bound ACh (protected from hydrolysis by AChE in the absence of a cholinesterase inhibitor).

Also

ACh synthesized by membrane bound ChAT is partially protected from
hydrolysis when excess AChE is added to the incubation medium, whereas ACh synthesized by soluble ChAT is not.

This membrane bound form

of ChAT may be functionally significant in neurotransmission.
Substrates for ChAT
ChAT catalyzes the synthesis of ACh from choline and acetyl CoA.
An exogenous supply of choline is required to maintain ACh synthesis
over a period of time since choline is not synthesized in the brain.
The concentration of choline present in the extracellular space is
maintained by choline from the plasma, and also choline resulting from
the hydrolysis of ACh by acetylcholineserase present in the synaptic
cleft.

Choline may also be partially supplied by the breakdown of

membrane lipids.

Uptake of choline into nerve terminals from the
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synaptic cleft is thought to occur by one of two transport processes:
low-affinity transport, with a Kt of 50-100 uM, and a high-affinity
transport, with a Kt of 1-5 uM.

The latter has been postulated to be

specific for cholinergic nerve endings (Kuhar

et~.,

1973), and also

to be coupled to ACh synthesis (e.g. Barker and Mittag, 1975) (see
reviews by Kuhar and Murrin, 1978; and Jope, 1980).
The origin of acetyl CoA for ACh synthesis in nerve endings is
presently unknown.

It is synthesized within mitochondria; but whether

acetyl CoA for ACh synthesis is generated at another location in the
nerve ending, remains to be elucidated.

An external source of acetate

groups is required to maintain ACh synthesis.

Several investigators

have found glucose and pyruvate to be good precursors,
(e.g. Tucek and Cheng , 1974)
Guyenet et

~J_.,

1973).

and~

both~

vitro (e.g. Lefresne

vivo

~! ~.,

1973;

Balfour and Hebb (1952) found that acetone

extract powders of brain tissue are able to synthesize ACh from
ine and either citrate or acetate.

chol~

Tucek (1967 a,b,c) has reported

that citrate-ATP lyase (EC 4. 1.3.8) and acetyl CoA synthase (EC 6.2. 1. 1)
(which synthesize acetyl CoA from citrate and acetate,
are at least partially extramitochondrial enzymes.
Sollenburg and Sorbo (1970), and

Sterling · ~dO'Neill

respectively)

Alternatively,
(1978) have sug-

gested that citrate may simply mediate the transport of the acetyl
moiety from mitochondria to the site of synthesis of ACh. Gibson and
Shimada (1980) report that citrate may not be the only intermediate
in acetyl CoA

metaboli~m

in brain tissue, but that acetate and carni-

tine may also be involved.

They also present evidence that acetyl CoA

involved in ACh synthesis may be distinguished from acetyl CoA involved
in lipid synthesis, by using (-) hydroxycitrate and n-butylmalonate,
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both inhibitors of citrate metabolism.

This agrees with a previous

study by Tucek and Cheng (1974) which reports that when rats were injected with [l,s- 14 c] citrate, the lipid stores in the brain became
labelled, whereas ACh did not.

However this last study only examined

whole brain ACh, and did not distinguish between the different subcellular pools of ACh.
Another alternative, proposed by Tucek (1967, c) is that acetyl
CoA may itself be .transported out of mitochondria during mitochondrial
contractions.
Kinetic mechanism of ChAT
Several different mechanisms have been proposed by different
groups of investigators on how ChAT catalyzes the synthesis of ACh.
Kinetic studies have often led to different conclusions for several
reasons.

ChAT has not yet been isolated in pure form and often enzyme

preparations may be contaminated with other proteins which interfere
with the assay.

Also ChAT decreases in specific activity the more it

is purified (Hebb, 1972).

Finally a variety of different species

have been used in kinetic studies.

In general, most investigators

believe that ChAT functions by the Theorell-Chance mechanism (e.g.
White and Wu, 1973, b; Morris

et~..!_.,

1971).

According to this mech-

anism of enzyme activity both the reactants (choline and acetyl CoA)
bind and the products (ACh and CoA) dissociate from the enzyme in a
particular order.

However, Hersh and Peet (1977) have suggested that

not all experimental evidence uniquely supports this type of mechanism.
These authors employed dead-end inhibitors and alternate substates,
and suggest that ChAT functions by a sequential random mechanism, in
which the substrates bind and the products dissociate in random order.

l'l

They indicate that product inhibition studies (in which ACh competitively inhibits acetyl CoA but noncompetitively inhibits choline) can
be also explained by the sequential random mechanism. Also, the deuterium isotope effect observed by Currier and Mautner (1974) (interpreted as general base catalysis) is not consistent with the Theorel l Chance mechanism.
Several investigators have attempted to classify ChAT as a sulfhydryl enzyme (i.e., the enzyme requires a free sulfhydryl group in
its active site) utilizing various sulfhydryl agents (e.g. Reisburg,
1957; Mannervik and Sorbo, 1970).

In general most investigators now

agree that ChAT contains "nonessential" sulfhydryl groups, and that
inhibition of ChAT by sulfhydryl reagents may be caused by conformational changes in the enzyme, and not by direct binding to the active site (e.g. White and Cavallito, 1970; see also review by Hebb,
1972).
Imidazole (or histidine) residues have -also been implicated by
Currier and Mautner (1974) among others (e.g. White and Cavallito,
1970), particularly in view of the previously mentioned general base
catalysis observed by these authors.

Imidazole groups have been

shown to activate ChAT (White and Cavallito, 1970; Hebb et 2-}_., 1975;
Davies, 1979) and may also synthesize ACh nonenzymatically (Burt and
Silver, 1973; Aquilonius and Eckernas, 1976).
Ionic requirements of ChAT h-ave also been studied by several
groups of investigators.
Cl

Rossier

~!

2-}_. (1977) demonstrated that only

activates ChAT solubilized from rat brain.

However, Hersh (1980)

found that all monovalent anions activate ChAT to the same extent.
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Guyenet

et~-

(1973) and Smith and Carroll (1980) have found that

ChAT is dependent on Na+ for activity. · Additionally, Hersh and his
coworkers (1978, a,b,c) demonstrated that enzyme activity and mechanism · may be regulated by ionic strength, and that divalent cations
. h"b"t
th e enzyme.
sue h as Ca++ an d Mg ++ in
i i

Studies using homocholine
Recent results obtained with the choline analog homocholine (3-trimethylamino propan-1-ol) support the possibility that the activity of
soluble ChAT may not be essential to the formation of transmitter released during depolarization (Collier
homocholine is shown in Fig. 1.

et~.,

Torpedo (van Schwarzenfeld

The structure of

Homocholine is similar to choline in

many aspects of cholinergic metabolism.
brain synaptosomes (Collier et

1977).

~_l.,

~!. ~.,

It is transported into rat

1977) and el ectroplaques of
1979; Luqmani et 2.l·, 1980) and is

acetylated and released as acetylhomocholine (AHCh) from the superior
cervical ganglion (Collier et 2.l·, 1977), guinea-pig cortex (von
Schwarzenfeld, 1979), Torpedo electroplaques (Luqmani

et~.,

1980)

and minces of mouse forebrain (Carroll and Aspry, 1980) by a Ca ++ dependent process during depolarization.

A crude vesicular (P 3 ) fraction of mouse forebrain, depleted of its acetylcholine content independently of the cytoplasm (S 3 ) by incubation of mouse forebrain
minces in a lithium-high potassium Krebs medium, can also be refilled
with either newly synthesized AHCh or new ly synthesized ACh formed
from their respective precursors homocholine or choline.

This refill-

ing does not occur by transfer of the acetylaterl product from the

s3

fraction since the ratio of newly synthesized to preformed transmitter
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in the P3 fraction exceeds that of the
1978; Nelson et~., 1980).

s3

fraction (Carroll and Nelson,

Homocholine, however, differs from choline in one very important
respect.

Homocholine is not acetylated by soluble ChAT (Burgen

et~.,

1956; Dauterman and Mehrotra, 1963; Currier and Mautner, 1974; Barker
and Mittag, 1975;

Collier~.!~.,

1977).

Therefore the objective of

this investigation was to determine if homocholine is acetylated by
the membrane associated form of ChAT present in the nerve endings of
mouse forebrain.
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MATERIALS AND METHODS
Choline and 3-heptanone (practical grade) were obtained from
Eastman Company (Rochester, NY) and the 3-heptanone was redistilled
(collected at 146-147°C).

Eserine sulfate and carnitine were pur-

chased from Sigma Chemical Company (St. Louis, MO) and 4-(1-naphthylvinyl) pyridine (NVP) and acetyl Coenzyme A from Calbiochem (La
Jolla, CA).

Sodium tetraphenylboron and toluene (spectanalyzed)

were purchased from Fisher Scientific Company (Fairlawn, NJ). Aquasol
II, Hyamine hydroxide, Liquifluor, [acetyl-l- 14 c] acetyl Coenzyme A
(spec. act. 48.3 mCi/mmol), [ 14 c] methyl iodide (spec. act. 31.0
mCi/mmol) and [ 14 c] acetylcholine (spec. act. 1.2 mCi/mmol) were purchased from New England Nuclear (Boston, MA). Homocholine, acetylhomocholine, [ 14 c] homocholine and [ 14 c] acetylhomocholine, were synthesized as described by Nelson et

~J_.

(1980).

Enzyme preparations
Male CD-1 albino mice were killed by cervical dislocation, the
forebrains quickly removed and placed into ice-cold Normal Krebs (composition in mM; NaCl, 117; KCl, 3.5; MgS0 4, 1.2; NaHC0 3, 28.0; KH 2Po 4 ,
1.2; CaC1 2, 2.5; Glucose, 11.0). They were blotted dry, weighed,
minced, and incubated for 15 min in Normal Krebs at 38°C.

Minces

were then washed twice with ice-cold 0.32 M sucrose, and subcellular
fractions prepared according to the method of Gray and Whittaker (1962),
as modified by Collier
(1976).

et~·

(1972) and Salehmoghaddam and Collier

Minces were homogenized in 5.0 ml of 0.32 M sucrose at 840

15
rpm with 8 up and down strokes.

This homogenate was spun at 1000 g

for 10 min, and the supernatant spun at 17,000 g for 15 min, to yield
a P2 (synaptosomal) pellet. Synaptosomes were hypo-osmotically ruptured by homogenizing the P2 pellet in 2.0 ml of water at 400 rpm using 8 up and down strokes.

This homogenate was spun at 100,000 g for

60 min to yield a crude vesicular fraction (P 3 ) and an
believed to contain soluble cytoplasmic contents. The

s3
s3

fraction
fraction was

discarded.

The P3 fraction, which contains occluded ACh, was then
washed twice with 1.0 ml of 100 mM sodium phosphate buffer (pH 7.4)
in order to remove ionically bound ChAT (Fonnum, 1968).

Approximate-

ly 703 of the ChAT activity recovered from the hypo-osmotically ruptured P2 fraction was present in the 100 mM sodium phosphate buffer
wash of the P3 fraction whereas 15% remained in the washed P3 (Smith
and Carroll, 1980).

The washed P3 fraction was then homogenized in
1.0 ml of water and layered on top of a discontinuous sucrose gradi-

ent containing 2 ml each of 0.4 M and 0. 6 M sucrose and spun at
192,000 g for 30 min.

The pellet was homogenized in 500 ul of water

and stored at -20°C until determinat i on of ChAT activity.

The 0.4 M

sucrnse layer was pelleted at 100,000 g for 60 min.

This fraction

was suspended in 200 ul of water for enzyme assay.

The 0.6 M frac-

tion was also pelleted at 100,000 g for 60 min and suspended in 500 ul
of water for enzyme assay.

P4, 0.4 Mand 0.6 M fractions were never
kept for more than 7 days, and the solubilized enzyme never more than
2 days, since it was noted that enzyme activity declined after these

times even though stored at -20°C.

In one set of experiments, the P4
fraction was washed with 1.0 ml of 100 mM sodium phosphate buffer,
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centrifuged at 100,000 g for 60 min and the ChAT activity determined
in the wash fraction as well as the washed P4 fraction.
Enzyme assays
ChAT activity in the various fraction was determined in duplicate
or triplicate by the method of McCamen and Hunt (1965) as modified by
Fonnum (1969).

Aliquots of 2 ul of the tissue fractions or the pooled

sodium phosphate buffer washes of the P3 fraction were incubated for
varying time periods (activity was linear for at least 30 min for all
substrate concentrations used) at 39°C, a temperature which activates
brain ChAT activity (Hebb, 1975), with 20 ul of a buffer substrate
consisting of the following components:

NaCl (234 mM), Bovine Plasma

Albumin (0.0375%), MgC1 2 (17mM), sodium phosphate buffer, pH 7.4
(84 mM), Eserine (150 uM), [ 14 c] acetyl Coenzyme A (343 uM, spec. act.
2 mCi/mmol) and one or several of the following substrates in the
concentrations indicated:
added substrate.

choline, homocholine, carnitine, or no

Acetyl CoA:

Carnitine-0-acetyltransferase (carnitine

acetyltransferase, EC 2.3. 1.7) activity was determined by replacing
choline with carnitine in the McCamen and Hunt assay.

In some experi-

ments the following compounds were tested as inhibitors of ChAT:
AHCh, and NVP.

ACh,

Stock solutions were prepared fresh in water (pH 4.0

for ACh and AHCh) and l ul aliquots were added to tissue samples just
prior to addition of the buffer substrates.

One ul of water (pH 4.0)

did not affect soluble or membrane bound ChAT activity.

NVP solu-

tions were always prepared in amber bottles and the assay conducted
in a darkened room, since NVP is light sensitive.
Following incubation, samples were chilled and the acetylated
products were extracted with 150 ul of sodium tetraphenylboron/
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3-heptanone (TPB/3-hept., 75 mg/ml).

One ml of Hyamine hydroxide was
added to 100 ul of the TPB/3-hept. extract and [ 14 CJ acetylated pro-

ducts were counted in 15 ml of toluene containing Liquifluor.

Acetyla-

tion was calculated from the specific activity of the buffer substrate,
which was counted in the presence of TPB/3-hept. (75 mg/ml) (extraction of acetylated products into 75 mg/ml TPB/3-hept. was essentially
complete).

Net acetylation was corrected for acetylation of endogen-

ous substrates.

Because of variability in the tissue preparation, all

experiments were conducted on forebrains from at least 6 experimental
animals except where indicated.
Chromatography
Tissue aliquots were incubated as;previously described except that
acetylated products were extracted with 5 mg/ml TPB/3-hept.

100 ul

of the organic phase was mixed with 50 ul lN HCl and aliquots of the
HCl pooled and dried.

Two ul of water was added to the dried extract

and the sample was streaked on a strip of Whatman #3 paper .

Acety~ -

lated products were separated by descending paper chromatography in a
ethanol:lN acetic acid: water (8:2:1:3)
and identified by comparison with [ 14 c] ACh and [ 14 c] AHCh standards

solvent system of n-butanol:

run simultaneously.

Labelled products were dissolved from 1 cm strips

in l ml of water and counted in Aquasol II.
Electron microscopy
Pellets obtained from the subcellular fractionation were fixed
in 1% formaldehyde in 50mM cacodylate buffer, and post-fixed in 1%
Oso 4 in Millonig's phosphate buffer.

They were then dehydrated in

ethanol and embedded in Spurr's resin according to standard procedures
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(Spurr, 1969).

Ultra-thin sections were stained with lead citrate and

uranyl acetate, and examined under an RCA EMU-3F electron microscope .
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RESULTS
Recovery of P3 ChAT activity following sucrose density gradient centrifugation.
Aliquots of the subcellular fractions of mouse forebrain were assayed for ChAT activity using 10 mM choline.

ChAT which is nonionical-

ly bound to the P3 fraction, i.e., ChAT which remains associated with
that fraction after two washes with 100 mM sodium phosphate buffer
(pH 7.4), formed 429.7_2: 71.4 nmol/g wet wt/hr of acetylated product
(n=4).

Approximately 81% of the ChAT activity associated with the

washed P3 fraction was recovered from the 3 fractions of the sucrose
density gradient: the 0.4 M sucrose fraction formed 9.0_:2.5 runol/g
wet wt/hr (n=24) and electron microscopy revealed that this fraction
is enriched with spherical organelles resembling vesicles; the 0.6 M
sucrose fraction formed 48.5_:14.9 nmol/g wet wt/hr (n=6); and the P4
fraction formed 289_2:61 nmol/g wet wt/hr (n=18). Electron micrographs
of this fraction revealed that it contains large membrane fragments,
which have spherical organelles associated with some fragments, similar to those shown in a recent report (von Schwarzenfeld, 1978).

In

the experiment in which the P4 fraction was homogenized in 1.0 ml of
100 mM sodium phosphate buffer (pH 7.4), centrifuged, and its ChAT
activity compared with an unwashed P4 fraction, the ChAT activity was
identical (353.4_:37.4 vs. 362.4_2:14.9 nmol/g wet wt/hr, n=3). ChAT
activity in the 100 mM sodium phosphate buffer wash of the P4 fraction
was not detectable. The P4 fraction, which also contains occluded

ACh (Carroll and Benishin, 1~79) most closely reflects the metabolic
activity of the P3, a conclusion supported by a recent publication in
which Torpedo electroplaques were studied (Luqmani ~! ~., 1980).
Therefore, this fraction was selected for the subsequent kinetic analyses.
Kinetics of homocholine acetylation by the P4 fraction.
The kinetic parameters for P4 ChAT activity as a function of added
homocholine were determined using substrate concentrations ranging
from 10 -5 to 10 -2 M. Each point represents the average velocity, corrected for acetylation of endogenous substrates, for 15 forebrains.
Results in Figure 2 indicate that the apparent Km value for homocholine
acetylation is 49 uM, and the apparent Vmax for homocholine acetylation
is 70 nmol/g wet wt/hr.

Boiling tissue prior to incubation with homo-

choline (10 mM, n=6) reduced the formation of acetylated products to
the level of tissue-free blanks.
Ability of NVP to inhibit choline and homocholine acetylation by the
P4 fraction.
Several reports have suggested that carnitine acetyltransferase,
which is present in cholinergic preparations, may acetylate cholinergic neurotransmitter precursors (White and Wu, 1973a; Tucek
1978).

et~.,

To determine if choline and/or homocholine are primarily

acetylated by P4 ChAT rather than carnitine acetyltransferase, aliquots of the P4 fraction were incubated either in the presence or absence of NVP, which inhibits ChAT but not carnitine acetyltransferase (White and Wu, 1973a).

Results shown in Fig. 3 indicate that NVP
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(4.6 uM) significantly reduces acetylation of choline (60%) and homocholine (40%), but stimulates acetylation of carnitine (18%) by the
P4 fraction.
Jnability of NVP to reduce acetylation of homocholine by solubilized
ChAT.
Results presented in Table 1 indicate that NVP (4.6 uM) significantly reduces choline acetylation by ChAT solubilized from the P3
fraction 76%. This fraction acetylates carnitine and homocholine very
poorly, and NVP does not alter acetylation of either substrate.
Does homocholine serve as a competitive alternative substrate to choline for acetylation by P4 ChAT?
Results obtained in this study with the ChAT inhibitor NVP suggest that both choline and homocholine are acetylated by ChAT in the
P4 fraction. To determine if both substrates are acetylated by the
same or different forms of ChAT in the P4 fraction, the kinetic parameters of choline acetylation were determined in the absence or presence of several fixed homocholine concentrations (0.5, 1.0, 5.0, or
10.0 mM) using 3 forebrains, according to the procedure of Ch.a (1968).
In this method, two potential substrates are simultaneously incubated
with the enzyme and the concentration of one substrate, A, is varied
while the other, B, is held constant, and the combined velocity of
products formed is determined.

In the present experiments, the com-

bined velocity equals the total amount of acetylated products formed,
i.e., [ 14 c] ACh and [ 14 c] AHCh. Both of these products behave
identically in the assay used and are extracted equally by TPB/3-hept.
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When both substrates are metabolized by the same enzyme and substrate
A is better than B (i.e., the Vmax for A exceeds t he V'max for B), then
a plot of l/v (combined velocity) vs. l/[A] will be hyperb·0 lic.

When

a series of kinetic plots are generated using different fixed levels
of substrate B or in the absence of B, and Vmax exceeds V'max' then the
curves generated will intersect at a common point.

A theoretical com-

mon point of intersection can be predicted from the following relationship:

S= V'max· Km/(Vmax-V'max) where S represents the concentration

of substrate A at the co1TITion point of intersection,and Km represents
the apparent Michaelis constant obtained for substrate A.
When the Vmax equals V'max the curves will merge at the Y axis
and not be straight lines.

If substrate B is not metabolized by the

same enzyme as A but competes with A for binding to the same enzyme,
then a series of straight lines is generated which yield similar Vmaxs.
If two enzymes. are involved in the metabolism of the two substrates,
the curves obtained will not intersect at one point.
Figure 4 depicts the pooled results obtained for two different
experiments where 1/v (combined velocity) vs. l/S (corrected for endogenous choline concentration) for each fixed homocholine concentration (0,0.5, 1.0, 5.0, or 10.0 mM) is plotted.

Values were normal-

ized by multiplying l/v by Vmax for choline and 1/S (corrected) by the
Km for choline for each of the two experiments.

The correlation coef-

ficients obtained for the least squares regression lines of the data
points (dotted lines) decrease as the concentration of homocholine is
increased.

Polynomial regression analysis shows that a second degree

polynomial fits the data points obtained better than a straight l i ne
when homocholine is present.

The combined plot (Figure 5) shows that the curves do in fact intersect at one common point as predicted when one enzyme metabolizes
both substrates.

When this experiment was repeated a third time with

another forebrain, kinetic plots yielded a similar pattern.
Table 2 summarizes the kinetic parameters obtained for choline and
homocholine for all three alternative substrate binding experiments.
The Vmax for choline acetylation (295 _:: 86 nmol/g wet wt/hr) exceeds
the V'max for homocholine acetylation (79 _:: 23 nmol/g wet wt/hr) by
approximately 3.7 fold.

The theoretical point of intersection (47 uM

choline) is similar to the actual point of intersection obtained for
the three experiments (52 _:: 5 choline).

The mean Vmax value for homo-

choline acetylation by P4 ChAT obtained using the Cha procedure
(79 _:: 23 nmol/g wet wt/hr, n=3) closely corresponds to the value obtained for homocholine acetylation by the method of Lineweaver and
Burk (1934) (70 nmol/g wet wt/hr, n=l5).
Does homocholine serve as a competitive alternative substrate to choline for acetylation by soluble ChAT?
Aliquots of the sodium phosphate buffer wash of the P3 fraction
were incubated with varying concentrations of choline in the absence
or presence of fixed homocholine concentrations (2.0, 10.0, 20.0 mM)
as described in the previous section for P4 ChAT. Again values were
normalized. The plot of Vmax/v vs. Km/S for the sodium phosphate
buffer was different (Figure 6) from that obtained for the P4 fraction.
For example, the correlation coefficients obtained for the least
squares regression lines do not change with increasing homocholine concentration and polynomial regression analysis indicates that the
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points are best fit by straight lines rather than second degree polynomials.

Regression coefficients increase with increasing homocholine

concentration and the Vmaxs for choline acetylation do not change with
increasing homocholine concentration suggestingthat homocholine competitively inhibits the binding of choline to soluble ChAT but is not
being acetylated.
Ability of ACh and AHCh to inhibit acetylation of choline by solubilized and P4 ChAT
ACh competitively inhibits choline acetylation by ChAT (Kaita and
Goldberg, 1969; White and Wu, 1973 b,c; Smith and Carroll, 1980).

To

determine if AHCh also inhibits acetylation of choline by soluble and/or
P4 ChAT, aliquots of the sodium phosphate buffer wash or P4 fraction
were incubated in the presence or absence of varying concentrations of
AHCh and compared with similar concentrations of ACh.

To insure that

the added inhibitor did not interfere with the extraction of labelled
acetylated product into the TPB/3-hept., ACh or AHCh was added to
some samples following incubation with the buffer substrate.

Their re-

spective effects on the amounts of acetylated products extracted into
TPB/3-hept. were determined to be negligible at the inhibitor concentration used.
ACh, as expected, inhibits acetylation of choline by ChAT in the
sodium phosphate buffer wash and the P4 (Figure 7). AHCh also inhibits
both soluble and P4 ChAT activity in a dose · dependent manner, and is
a more potent inhibitor of both enzyme forms than is ACh.

Dixon plots

of ACh inhibition of P4 ChAT and AHCh inhibition of P4 and soluble
ChAT indicate that inhibition is competitive in all 3 cases, as
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illustrated in Figures 8, 9, and 10.

Plots of l/v of AHCh or ACH con-

centrati on for the different concentrations of choline (1.1 and 4.3 mM)
intersect in tht fourth quadrant, which is consistent with competitive
inhibition, and yield Kis of 63mM, lOmM, and 200mM, respectively.

DISCUSSION
In agreement with the results of others (Burgen et i.!_., 1956;
Dauterman and Mehrotra, 1963; Currier and Mautner, 1974; Collier et i.!_.,
1977), the choline analog homocholine does not appear to be acetylated
by soluble ChAT.

The ChAT inhibitor NVP (Krell and Goldberg, 1975)

does not reduce its acetylation at a concentration which reduces choline acetylation by

approxi~ately

75%.

It does,however, compete with

choline for binding to soluble ChAT since its presence alters the
kinetic plots obtained for choline acetylation in a mamersuggestive
of competitive binding (Cha, 1968).
Homocholine, like choline, is acetvlated by a form of ChAT which
is nonionically associated with a fraction of mouse forebrain nerve
endings that contains both occluded ACh and subcellular organelles
associated with neuronal membranes (P 4 ). Acetylation of homocholine
by this fraction is saturable and inhibited by the ChAT inhibitor NVP.
Homocholine alters the kinetic plots obtained for P4 ChAT as a function of choline in a manner which suggests that both it and choline
are acetylated by the same ChAT in the P4 fraction. Choline is a superior substrate to homocholine for acetylation by ChAT in the P4
since the Vmax value obtained for choline by the method of Lineweaver
and Burk (1934) (295

! 86 nmol/g wet wt/hr, n=3) exceeds the V'max

values obtained for homocholine using either the method of Lineweaver
and Burk (70 nmol/g wet wt/hr, n=l5) or that of Cha (79 + 23 nmol/g
wet wt/hr, n=3) by almost 4-fold.
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Several results obtained in the present study and a previous one
(Smith and Carroll, 1980) indicate that membrane associated ChAT does
not represent soluble ChAT which has become artificially associated
with membranes during tissue preparation or soluble ChAT contained in
nondisrupted synaptosomes.

When the P4 fraction is washed with 100
mM sodium phosphate buffer following sucrose density gradient centrifugation rather than suspended in distilled water, the ChAT activity
determined in the washed and unwashed P4 fractions is identical. This
result indicates that suspension of the P3 fraction in distilled water
prior to sucrose density gradient centrifugation does not cause soluble ChAT to bind ionically to membranes recovered in the P4 fraction.
Addition of excess acetylcholinesterase during the initial brain homogenization hydrolyzes at least 90% of the ACh formed by s3 without
hydrolyzing any ACh formed by the P3 fraction washed twice with 100 mM
sodium phosphate buffer (pH 7.4) indicating that tissue homogenization
does not form subcellular organelles which trap cytoplasmic ChAT.

NVP

inhibits the acetylation of homocholine by membrane bound but not soluble ChAT, whereas it reduces the acetylation of choline by soluble
ChAT to a greater extent than it reduces the acetylation of choline by
membrane bound ChAT.

If homocholine were acetylated by soluble ChAT

contained in nondisrupted synaptosomes associated with the P4 fraction,
then NVP should inhibit the acetylation of homocholine by soluble
ChAT to a greater extent than it reduces acetylation of homocholine
by the P4 fraction and it clearly does not. Homocholine competitively
inhibits the binding of choline to soluble ChAT but is not itself
acetylated by this form of the enzyme.

Conversely, it competitively
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inhibits the binding of choline to membrane bound ChAT and is acetylated.
Results presented here appear to differ from those of Boksa and
Collier (1980) who concluded that homocholine is probably a substrate
for ChAT based

on~

situ evidence, but were unable to demonstrate ap-

preciable acetylation of homocholine

~vitro

relative to choline.

Their investigation, in contrast to this experimental protocol, encouraged the association of soluble nerve ending ChAT to membranes by
suspending ruptured synaptosomes in a low osmotic strength medium.
Then they compared the ability of membrane associated ChAT to acetylate choline and homocholine and were unable to detect appreciable
acetylation of homocholine relative to choline.

The ability to detect

acetylation of homocholine by membrane bound ChAT may be due to the
fact that nerve ending ChAT was separated into soluble (acetylates
choline but not homocholine, and represents at least 70% of nerve end; ng ChAT) and membrane bound ChAT ( acetyl ates cha H ne better than homochol ine and only represents 15% of nerve ending ChAT).
Both AHCh and ACh compete with choline for binding to ChAT, as
illustrated by the Dixon plots.

The product AHCh is more potent than

ACh in inhibiting ChAT solubilized from the P3 fraction and ChAT nomionically associated with the P4 fraction. As Cha et al. (1975) have
suggested, the larger chain analog may become "wedged" in the catalytic site and act as a more potent inhibitor than the natural end
product.

TABLE l.

~;·:C-~

.!~,.-·'.

,.~v.~

1w.< ...

ABILITY OF NVP TO INHIBIT

ACETY ~ ATION

OF CHOLINE, HOMOCHOLINE AND CARNITINE

BY ChAT SOLUBILIZED FROM A CRUDE VESICULAR FRACTIONa

CHOLINE
CONTROL

908 +

114 ( 12 )

NVP (4.6 uM)

217 + 46 (12)b

HOMOCHOLINE

CARN ITINE

78 + 22 (12)

136 + 16 (6)

65 + 24 (12)

123 + 8 (6)

aAliquots of subcellular fractions were incubated with either 10 mM choline or 10 mM homocholine,
or 1.2 mM carnitine for 30 min at 39°C, and amounts of acetylated products determined following
correction for acetylation of endogenous substrates. Results are expressed as nmol of acetylated
product formed/g wet wt/hr.
bResults significantly different from control at P< 0.05 (t -test, unpaired).

N
~

TABLE 2.

KINETIC VALUES FOR THE COMPETITIVE ALTERNATIVE SUBSTRATES OF P4 ChAT, CHOLINE AND HOMOCHOLINEa

Km (choline)

vmax (choline)

V'max (homocholine)

s

(uM)

(nmol/g wet wt/hr)

(nmol/g wet wt/hr)

(uM)

EXPT. l

123

465

125

45

EXPT. 2

144

187

50

52

EXPT. 3

172

233

61

61

146 + 14

295 -+ 86

79 + 23

52 + 5

Mean -+ S.E.M.

-

THEORETICAL
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aNormalized values from Expt. 1 and Expt. 2 are illustrated in Fig. 3 and 4. In all three experiments,
the K and Vmax for choline were determined from line A (0 Homocholine). V'max for homocholine was
calcu~ated from the Y-coordinate of the point of intersection (Vmaxlv = V'max• Cha, 1968). S, the choline concentration at which homocholine appears to have no effect, was determined from the X-coordinate
of the point of intersection (K /S). The theoretical value for S was determined from a plot of the theoretical equation
m
Vmax (S)

v

=

Vmax (S')

---+---K' m
Km

~~~~~~~~~~-

l+ill+~
1
K
m Km
where Km· and V were the means from these three experiments (146 uM and 295 nmol/g wet wt/hr, respectively), aW8xK'm and V'max obtained from Fig. 1 (49 uM and 70 umol/g wet wt/hr, respectively).
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+

{CH3) N-CH2- CH2-CHz-OH

Figure 1.

The structure of choline and the analog homocholine.
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Figure 2.

Lineweaver-Burk plot of homocholne acetylation of P4 ChAT.
2 ul aliquots of the P4 fraction were incubated at 39° for
15 min in the presence of varying concentrations of homochol ine ranging from 1 x 10- 5 M to 1 x 10- 2 M. Each point
represents the average velocity for 15 forebrains (each
forebrain assayed in duplicate), after correction for acetylation of endogenous substrates.
~alues

The apparent Km and Vmax

for homocholine acetylation are 49 uM and 70 nmol/g

wet wt/hr, respectively, as calculated from the least
squares regression line (Y = 0.00072 x + 0.0147; r

=

.997).
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Figure 3.

Ability of the ChAT inhibitor NVP to inhibit the acetylation
of choline and homocholine but not carnitine by the P4 fraction. 2 ul aliquots of the P4 fraction were incubated at
39° for 30 min in the presence of the substrates indicated
and the effect of NVP (4.6 uM) determined on the formation
of acetylated products.

Amounts of acetylated products

formed were corrected for acetylation of endogenous substrates.

( ) = number of experimental animals.

An asterisk

indicates that NVP treatment differs from contra 1 at P < 0. 05
(t-test, unpaired).
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Figure 4.

Ability of homocholine to serve as an alternative substrate
to choline for acetylation by P4 ChAT . 2 ul aliquots of
the P4 fraction were incubated at 39° for 15 min with added
choline concentrations ranging from 20 to 1000 uM and either
no added homocholine or with one fixed homocholine concentration (0.5, 1.0, 5.0, or 10.0 mM).

Results from two sep-

arate experiments (two forebrains) are included in each plot.
corresponds to Expt 1 and
see Table 2.

corresponds to Expt 2;

Choline concentrations were corrected for

endogenous choline.

Values were normalized by multiplying

l/v by Vmax for choline and l/S (corrected) by Km for choline for each experiment.

Least squares regression lines

(---) for each homocholine concentration are included along
with the correlation coefficients (r).

Curved

lines(~ )

through the data points of different kinetic plots were
drawn independently.
present,

In all cases where homocholine was

polynomial regression analysis indicated that a

second degree polynomial fit the data point better than a
straight line.
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Figure 5.

Combined kinetic determinations of P4 ChAT activity as a
function of added choline in the absence and presence of
fixed homocholine.

Superimposing the individual curves

shown in Fig. 4 results in the curves intersecting at one
common point, a result interpreted by Cha (1968) to indicate that both substrates are metabolized by the same enzyme.

The Y coordinate of the point of intersection is

3.7, which indicates that the Vmax for P4 ChAT as a function
of choline exceeds the V'max for P4 ChAT as a function of
homocholine by 3.7 fold.

The X coordinate (2.75) repre-

sents the concentration of choline (48.5 uM) at which homocholine, irrespective of its concentration, has no effect
on the velocity of the total acetylated products being
formed (Km= 133.5 uM choline/2.75 = S (48.5 uM choline).
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Figure 6.

Ability of homocholine to competitively inhibit choline
acetylation by soluble ChAT but not serve as a substrate.
2 ul aliquots of the sodium phosphate buffer wash of the
P3 fraction were incubated for 15 min at 39° with varying concentrations of added choline ranging from 50 to
1200 uM, and in the absence or presence of fixed levels
of homocholine (2.0, 10.0, 20.0 mM).

The least squares

regression lines and correlation coefficients are as
follows:
A (0 homocholine) Y = 1.0007 x + 0.995

r

= 0.94

B (2 mM homocholine) Y = 1.350 x + 0.814

r

= 0.99

C (10 mM homocholine) Y = 1.470 x + 0.916

r

= 0.98

D (20 mM homocholine) Y = 2.024 x + 0.754

r

= 0.99

Polynomial regression analysis indicated that in all
cases a straight line fit the data better than a second
degree polynomial.
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Figure 7.

Ability of ACh and AHCh to inhibit acetylation of choline
by soluble and P4 ChAT. 2 ul aliquots of sodium phosphate
buffer wash or the P4 fraction were incubated for 15 min
at 39° with 1. 1 mM choline and varying concentrations of
either ACh or AHCh.

An asterisk indicates that ACh or

AHCh treatment differs from control at P< 0.05.
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Figure 8.

Dixon plot of acetylhomocholine inhibition of choline
acetylation by P4 ChAT. 2 ul aliquots of the P4 fraction were incubated for 15 min at 39° in the presence
of choline (1. 1 or 4.3 mM) and varying concentrations
of acetylhomocholine.

l/v (choline acetylation) is

plotted as a function of acetylhomocholine concentration.

Acetylhomocholine did not interfere with the
extraction of [ 14 c] ACh into TPB/3-hept. at the concentrations used here.

Intersection in the fourth

quadrant indicates competitive inhibition; Ki= 63 mM.
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Figure 9.

Dixon plot of acetylhomocholine inhibition of choline
acetylation by soluble ChAT.

2 ul aliquots of the

sodium phosphate buffer wash were incubated for 15 min
at 39° in the presence of choline (1. 1 or 4.3 mM) and
varying concentrations of acetylhomocholine, l/v
(choline acetylation) is plotted as a function of
acetylhomocholine concentration.

Acetylhomocholine
did not interfere with the extraction of [ 14C] ACh into
TPB/3-hept. at the concentrations used here.

Inter-

section in the fourth quadrant indicates competitive
inhibition; Ki = 10 mM.
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Figure 10.

Dixon plot of acetylcholine inhibition of choline acetylation by P4 ChAT. 2 ul aliquots of the P fraction
4
were incubated for 15 min at 39° in the presence of choline (1. l or 4.3 mM} and varying concentrations of
acetylcholine.

l/v (choline acetylation} is plotted as

a function of acetylcholine concentration.

Acetylcho-

1ine dicl not interfere with extraction of [ 14 c] ACh into
TPB/3-hept. at the concentrations used here.

Intersec-

tion in the fourth quadrant indicates competitive inhibition; Ki= 200 mM.

0

49

0

N

0
IQ

l&J

l&J

~

z _J
-o
_J %

0

0 (,)

%

2

...

c

. I:.

.

2E

e ,.,
J

~

0
<t

(,) :&

:::

-

0

IC

I

a o

0
IQ

0
0

.

1 .(lt/.~M ieM 5/WU)~I

0
0

•
0

IQ

I

0
0

0

-

IC
I

0

0

N
I

0

IC
N
I

0

,,,0
I

50

LITERATURE CITED
Aquilonius, S.-M. and Eckernas, S.-A. (1976) Choline acetyltransferase in human cerebrospinal fluid: nonenzymatically and enzymatically
catalyzed acetyJcholine synthesis. J. Neurochem.,~:317-318.
Balfour and Hebb, C. (1952) Mechanisms of acetylcholine synthesis.
J. Phys i ol. (London), 118: 94- 106.
Barker, L.A. and Mittag, T.W. (1975) Comparative studies of substrates
and inhibitors of choline transport and choline acetyltransferase.
J. Pharmacol. Exp. Ther., 192:86-94.
Birks, R.I. and Macintosh, F.C. (1961) Acetylcholine metabolism of a
sympathetic ganglion. Can. J. Biochem. Physiol., 39:787-827.
Boksa, P. and Collier, B. (1980) Acetylation of homocholine by rat
brain: subcellular distribution of acetylhomocholine and studies on
the ability of homocholine to serve as a substrate for choline acetyltransferase in situ and in vitro. J. Neurochem., 34:1470-1482.
Burgen, A.S.V., Burke, G. and Desbarates-Schonbaum, M.-L. (1956) The
specificity of brain choline acetylase. Brit. J. Pharmacol. and
Chemother., _l.l:308-312.
Burt, A.M. and Silver, A. (1973) Histochemistry of choline acetyltransferase: a critical analysis. Brain Res., 62:509-516.
Carroll, P.T. and Nelson, S.H. (1978) Cholinergic vesicles: ability
to empty and refill independently of cytoplasmic acetylcholine.
Science, 199:85-86.
Carroll, P.T. and Benishin, C.G. (1979) Evidence that one pool of
cholinergic vesicles can empty and refill with newly synthesized
acetylcholine and acetylhomocholine independently of the monodisperse pool of cholinergic vesicles. Soc. Neurosci. Abstr., ..§_:737.
Carroll, P.T. and Aspry, J.M. (1980) Subcellular origin of cholinergic transmitter release from mouse brain. Science (in press).
Cha, S. (1968) Kinetics of enzyme reactions with competing alternative substrates. Mol. Pharmacol., ±:621-629.
Cha, S., Agarwal, R.P. and Parks, R.E. (1975) Tight-binding inhibitors-II: Non-steady state nature of inhibition of milk xanthine
oxidase by allopurinol and alloxanthine and of human erythrocytic
adenosine deaminase by coformycin. Biochem. Pharmacol., 24:2187-2197.

51
Chakrin, L.W., Marchbanks, R.M., Mitchell, J.F. and Whittaker, V.P.
(1972) The origin of the acetylcholine released from the surface of
the cortex. J. Neurochem., 12.:2727-2736.
Collier, B., Poon, P. and Salehmoghaddam.(1972) The formation of choline and of acetylcholine by brain in vitro. J. Neurochem., 12.=
51-60.
Collier, B., Lovat, S., Ilson, D., Barker, L.A. and Mittag, T.W. (1977)
The uptake and release of homocholine: studies with rat brain synaptosomes and cat superior cervical ganglion. J. Neurochem., 28:331-339.
Currier, S.F. and Mautner, H.G. (1974) On the mechanism of action of
choline acetyltransferase. Proc. Nat. Acad. Sci. USA, ll_:3355-3358.
Dauterman and Mehrotra. ( 1963) The N-alkyl group specificity of choline acetylase from rat brain. J. Neurochem., _!Q:ll3-117.
Davies, C.P. (1979) Stimulation of choline acetylase by histidine dipeptides. J. Neurochem., 1£:677-680.
del Castillo, J. and Katz, B. (1954) Quantal components of the endplate potential. J. Physiol. (London), 124:560-573.
del Castillo, J. and Katz, B. (1957) La base "quantale" de la transmission neuromusculaire. In Microphysiologie Comparee des Elements
Excitables (Colloques Int. du Centre National de la Recherche Scientifique n°67, Paris Gif/Yvette, C.N.R.S.) pp. 245-258.
de Robertis, E. and Bennett, H.S. (1954) Submicroscopic vesicular
component in the synapse. Fed. Proc., _l1:38.
de Robertis, E. and Bennett, H.S. (1955) Some features of the submicroscopic morphology of synapses in frog and earthworm. J. Biophys.
Biochem. Cytol., _!_:47-58.
De Robertis, E., Rodriguez de Lores Arnaiz G., Salganicoff, L.,
Pelligrino de Iraldi A., and Ziehler, L.M. (1963) Isolation of synaptic vesicles and structural organization of the acetylcholine system
within brain nerve endings. J. Neurochem., ..!Q.:225-235.
Fatt, P. and Katz, B. (1951) An analysis of the end-platepotential
recorded with an intracellular electrode. J. Physiol. (London), 115:
320-370.
Fatt, P. and Katz, B. (1952) Spontaneous subthreshold activity at motor
nerve endings. J. Physiol. (London), JJ..Z.:109-128.
·
Fatt, P. and Katz, B. (1953) Cherne-receptor activity at the motor endplate. Acta Physiol. Scand., 29:117-125.

52

Feigenson, M.E. and Barrnett, R.J. (1977) Combined pharmacological
and fine-structural studies of choline-0-acetyltransferase at the
myoneural junction. Brain Res., 119:155-179.
Fonnum, F. (1967) The compartmentation of choline acetyltransferase
within the synaptosome. Biochem. J., 103:262-270.
1

1

Fonnum, F. (1968) Choline acetyltransferase ·binding to and release
from membranes. Biochem. J., 109:389-398.
Fonnum, F. (1969) Radiochemical micro assays for the determination
of choline acetyltransferase and acetylcholinesterase activities.
Biochem. J., .J...l2:465-472.
Gibson, G.E. and Shimada, M. (1980) Studies on the metabolic pathway
of the acetyl group for acetylcholine synthesis. Biochem. Pharmacol.,
29:167-174.
Garia, A., Hurlbut, W.P. and Ceccarelli, B. (1978) Acetylcholine compartments in mouse diaphragm. A comparison of the effects of black
. widow spidow venom, electrical stimulation, and high concentrations
of potassium. J. Cell Biol., 78:716-733.
Gray, E.G. and Whittaker, V.P. (1962) The isolation of nerve endings
from brain: an electron microscopic study of cell fragments derived
by homogenization and centrifugation. J. Anat., 96:79-88.
Guyenet, P., Lefresne, P., Rossier, J., Beaujouan~ J.C. and Glowinski,
J. (1973) Inhibition by hemicholinium-3- of [ 14c] acetylcholine
synthesis and [3H] choline high affinity uptake into synaptosomes.
Malec. Pharmacol.~ ~:630-639.
Hebb, C.O. and Smallman, B.N. (1956) Intracellular distribution of
choline acetylase. J. Physiol. (London), 134:385-392.
Hebb, C. 0. and ~Jh itt aker, V. P. ( 1958)
acetylcholine and choline acetylase.
187-196.

Intracellular distribution of
J. Phys i a 1. (London), 142:

Hebb, C.O., Mann, S.P. and Mead, J. (1975) Measurement and activation of choline acetyltransferase. Biochem. Pharmacol., 24:1007-1011.
Hersh, L.B. and Peet, M. (1977) Re-evaluation of the kinetic mechanish of the choline acetyltransferase reaction. J. Biol. Chem.,
252:4796-4802.
Hersh, L.B., Barker, L.A. and Rush, B. (1978a) Effect of sodium
chloride on changing the rate limiting step in the human placental
choline acetyltransferase reaction. J. Biol. Chem., 253:4966-4970.
Hersh, L.B., Coe, B. and Casey, L. (1978b) A fluorometric assay for
choline acetyl transferase and its use in the purification of the
enzyme from human placenta. J. Neurochem., 30:1077-1085.

53
Hersh, L.B. and Peet, M. (1978c) Effect of salts on the physical and
kinetic properties of human placental choline acetyltransferase.
J. Neurochem., 30:1087-1093.
Hersh, L.B. (1980) Studies on the kinetic mechanism and salt activation of bovine brain choline acetyltransferase. J. Neurochem., 34:
1077-1081.
Heuser, J.E. and Reese, T.S. (1973) Evidence for recycling of synaptic
vesicle membrane during transmitter release at the frog neuromuscular
junction. J. Cell. Biol., 57:315-344.
Heuser, J.E., Reese, T.S. and Landis, D.M.D. (1974) Functional changes
in frog neuromuscular junction studied with freeze-fracture. J. Neurocytol., 1_:109-131.
Israel, M., Dunant, Y. and Manaranche, R. (1979). The present status
of the vesicular hypothesis. Prog. Neurobiol., _!1:237-275.
Jope, R.S. (1979) High affinity choline transport and acetyl CoA production in brain and their roles in the regulation of .acetylcholine
synthesis. Brain Res. Reviews, 1:313-344.
Kaita, A.A. and Goldberg, A.M. (1969) Control of acetylcholine synthesis--the inhibition of choline acetyltransferase by acetylcholine.
J. Neurochem., _Ji:ll85-1191.
Kasa, P. (1970) Identification of cholinergic neurons in the spinal
cord: an electron histochemical study of choline acetyltransferase.
J. Physiol. (London), 210:89-90P.
Kasa, P. (1975) Histochemistry of choline acetyltransferase.
Cholinergic Mechanisms (ed. P.G. Waser), Raven Press, N.Y.

In

Katz, B. and Miledi, R. (1977) Transmitter leakage from motor nerve
endings. Proc. R. Soc. Lond. B, 196:59-72.
Krell, R.D. and Goldberg, A.M. (1975) Effect of choline acetyltransferase inhibitors on mouse and guinea-pig brain choline and acetylcholine. Biochem. Pharmacol., 24:391-396.
Kuczenski, R., Segal, D.S. and Mandell, A.J. (1975) Regional and subcellular distribution and kinetic properties of rat brain choline
acetyltransferase--some functional considerations. J. Neurochem.,
24:39-45.
Kuhar, M.J., Sethy, V.H., Roth, R.H. and Aghajanian, G.K. (1973).
Choline: selective accumulation by central cholinergic neurons.
J. Neurochem., 20:581-593.
Kuhar, M.J. and Murrin, L.C. (1978) Sodium-dependent high affinity
choline uptake. J. Neurochem., 30:15-21.

54

Lefresne, P., Guyenet, P. and Glowinski, J. (1973) Acetylcholine synthesis from [2-14c] pyruvate in rat striatal slices. J. Neurochem.,
20: 1083- 1097.
Lineweaver, H. and Burk; 0. (1934) Determination of enzyme dissociation constant. J.A.C.S., 56:658-666.
Luqmani, Y.A., Sudlow, G. and Whittaker, V.P. (1980) Homocholine and
acetylhomocholine: false cholinergic transmitters in the cholinergic
electromotor system of Torpedo. Neuroscience, ~:153-160.
Macintosh, F.C. and Collier, B. (1976) Neurochemistry of cholinergic
terminals. In Handbook of Experimental Pharmacology, Vol. 42
(eds. E. Zaimes and J. Maclagen) Springer, Berlin.
Mannervik, B. and Sorbo, B. (1970) Inhibition of choline acetyltransferase from bovine caudate nucleus by sulfhydryl reagents and activation of the inhibited enzyme. Biochem. Pharmacol., _J1:2509-2516.
Marchbanks, R.M. and Israel, M. (1972) The heterogeneity of bound
acetylcholine and synaptic vesicles. Biochem. J., 129:1049-1061.
McCamen, R.E. and Hunt, J.M. (1965) Microdetermination of choline
acetylase in nervous tissue. J. Neurochem., _Jl:253-259.
Molenaar, P.C., Nickolson, V.J. and Polak, R.L. (1973) Preferential
release of newly synthesized 3H-acetylcholine from rat cerebral cortex
slices in vitro. Brit. J. Pharmacol. 47:97-108.
Morris, 0., Maneckjee, A. and Hebb, C. (1971) The kinetic properties
of human placental choline acetyltransferase. Biochem. J., 125:
857...,863.
Nelson, S.H., Benishin, C.G. and Carroll, P.T. (1980) Accumulation and
metabolism of choline and homocholine by mouse brain subcellular fractions. Biochem. Pharmacol. 29:1949-1957.
Palade, G.E. and Palay, S.L. (1954) Electron microscope observations
of interneuronal and neuromuscular synapses. Anat. Rec., 118:335-336.
Reisberg, R.B. (1957) Properties and biological significance of cho1ine acetylase. Yale J. Biol. Med., 29:403-435.
Richter, J.A. and Marchbanks, R.M. (197la) Synthesis of radioactive
acetylcholine from [3H] choline and its release from cerebral cortex
slices in vitro. ~Neurochem., ~:691-703.
Richter, J.A. and Marchbanks, R.M. (197lb) Isolation of [3H] acetylcholine pools by subcellular fractionation of cerebral cortex slices
incubated with [3H] choline. J. Neurochem., 18:705-712.

,.55

Rossier, J., Spantidakis, Y. and Benda, P. (1977) The effect of Cl
on choline acetyltransferase kinetic parameters and a proposed role
for Cl- in the regulation of acetylcholine synthesis. J. Neurochem.
29: 1077-1012.
Salenhmoghaddan, S.H. and Collier, B. (1976) The relationship between acetylcholine release from brain slices and the acetylcholine
content of subcellular fractions prepared from brain. J. Neurochem.,
27:71-76.
Smith, C.P. and Carroll, P.T. (1980) A comparison of solubilized and
membrane bound forms of choline-0-acetyltransferase (EC 2.3. 1.6) in
mouse brain nerve endings. Brain Res., 185:363-371.
Sollenburg and Sorbo, B. (1970) On ~he origin of the acetyl moiety
of acetylcholine in brain studied with a differential labelling
technique using 3H_l4c mixed labelled glucose and acetate. J. Neurochem., ..!2.:201-207.
Spurr, A.R. (1969) A low-viscosity epoxy resin embedding medium for
electron microscopy. J. Ultrastructure Res., ~:31-43.
Sterling, G.H. and O'Neill, J.J. (1978) Citrate as the precursor of
the acetyl moiety of acetylcholine. J. Neurochem., .l}_:525-530.
Suszkiw, J.B. (1976) Acetylcholine translocation in synaptic vesicle
ghosts...:!..!:!. vitro. J. Neurochem., .£Z_:853-857.
Tucek, S. (1966a) On subcellular localization and binding of choline
· acetyltransferase to the cholinergic nerve endings of the brain.
J. Neurochem., 13:1317-1327.
Tucek, S. (1966b) On the question of the localization of choline
acetyltransferase to the cholinergic nerve endings of the brain.
J. Neurochem., 11:1329-1332.
Tucek, S. (1967a) Observations on the subcellular distribution of
choline acetyltransferase in the brain tissues of mammals and comparisons of acetylcholine synthesis from acetate and citrate in
homogenates and nerve endings. J. Neurochem., __!i:519-529.
Tucek, S. (1967b) Subcellular distribution of acetyl CoA synthetase,
ATP citrate lyase, citrate synthase, choline acetyltransferase,
fumarate hydrolase, and lactate dehydrogenase in mammalian brain
tissue. J. Neurochem. 14:531-545.
Tucek, S. (1967c) The use of choline acetyltransferase for measuring the synthesis of acetyl coenzyme A and its release from brain
mitochondria. Biochem. J., 104:749-756.
Tucek, S. and Cheng, S.-C. (1974) Provenance of the acetyl group of
acetylcholine and compartmentation of acetyl CoA and Krebs cycle
intermediates in the brain in vivo. J. Neurochem., 22:893-914.

56
Tucek, S., Zelena, J., Ge I. and Vyskocil, F. (1978) Choline acetyltransferase in transected nerves, denervated muscles and Schwann cell
of the frog: correlation of biochemical, electron microscopal and
electrophysiological observations. Neuroscience, 1_:709-724.
van Scwharzenfeld, I. (1978) The uptake of acetylpyrrolidinecholine a false cholinergic transmitter - into mammalian cortical synaptic
vesicles. In Cholinergic Mechanisms and Psychopharmacology (ed. D.J.
Jenden). Plenum Press, N.Y.
van Schwarzenfeld, I. (1979) Origin of transmitters released by electrical stimulation from a small metabolically very active vesicular
pool of cholinergic synapses in guinea-pig cerebral cortex. Neuroscience, i= 477-493.
van Scwharzenfeld, I., Sudlow, G. and Whittaker, V.P. (1979) Vesicular
storage and release of cholinergic false transmitters. Prag. Brain
Res., 49:163-174.
White, H.L. and Cavallito, L.J. (1970) Choline acetyltransferase.
Enzyme mechanism and mode of inhibition by a styrylpyridine analog.
Biochim. Biophys. Acta, 206:343-358.
White, H.L. and Wu, J.C. (1973a) Choline and carnitine acetyltransferases of heart. Biochemistry, Jl.:841-846.
White, H.L. and Wu, J.C. (l973b) Kinetics of choline acetyltransferases
(EC 2.3.l.6) from human and other mammalian central and peripheral
nervous tissues. J. Neurochem., 20:297-307.
White, H.L. and Wu, J.C. (1973c) Separation of apparent multiple
forms of human brain choline acetyltransferase by isoelectric
focusing. J. Neurochem., .£}_:939-947.
Whittaker, V.P., Michaelson, I.A. and Kirkland, R.J.A. (1964)
separation of synaptic vesicles from nerve-ending particles
1
(
synaptosomes 1 ) . Biochem. J., 90:293-303.

The

